RecruitingPhase 3NCT06439082A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)Sponsor: Novartis PharmaceuticalsFlowood, MS · +16 more sites
RecruitingPhase 3NCT06975865The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell DiseaseSponsor: SanofiFlowood, MS · +20 more sites
RecruitingPhase 3NCT07656415A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)Sponsor: Agios Pharmaceuticals, Inc.Flowood, MS · +2 more sites
RecruitingPhase 2 / Phase 3NCT05431088A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCDSponsor: PfizerFlowood, MS · Madison, MS · +44 more sites
RecruitingPhase 2NCT07224360Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)Sponsor: CSL BehringFlowood, MS · +8 more sites